Bindu Chamarthi MD
Diabetes, Lipid Metabolism
Endocrinologist, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School; Medical Director, VeroScience, LLC
Join to View Full Profile
221 Longwood AveBoston, MA 02115
Phone+1 617-732-5556
Fax+1 617-525-0439
Dr. Chamarthi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
Harvard Medical SchoolMasters in Medical Science (MMSc), Clinical Research, 2009- Brigham and Women's HospitalFellowship, Hypertension/Cardiovascular Endocrine Research Program, 2005 - 2007
Boston University Medical CenterFellowship, Heart Failure/Cardiomyopathy Program, 1998 - 1999- Boston University Medical CenterResidency, Internal Medicine, 1995 - 1998
Certifications & Licensure
MA State Medical License 1997 - 2027
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Evaluation of Lysine-Specific Demethylase 1 Start of enrollment: 2012 Jul 01
- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
- Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 9 citationsBromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2...Anthony H Cincotta, Eugenio Cersosimo, Mariam Alatrach, Michael Ezrokhi, Christina Agyin
International Journal of Molecular Sciences. 2022-08-09 - 8 citationsCircadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.Bindu Chamarthi, Aaron I. Vinik, Michael Ezrokhi, Anthony H. Cincotta
Endocrinology, Diabetes & Metabolism. 2020-01-01 - 38 citationsTCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Respon...Shylaja Srinivasan, Varinderpal Kaur, Bindu Chamarthi, Katherine R. Littleton, Ling Chen
Diabetes Care. 2018-01-11
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- VeroScience, LLC, Medical Director2013 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
